Meisoindigo
甲异靛
Report date: 2022/04/11 15:49:38
NME
Base Information
Drug NameMeisoindigo
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2001/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Union Pharmaceutical FactoryInstitue Of Materia Medica Chinese Academy Of Medical ScienceChinese Academy Of Medical Sciences
China Registration ClassN/A
Develop Information
Active CompaniesTakeda Pharmaceutical Co LtdBeijing Union Pharmaceutical Factory
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A